122
Views
15
CrossRef citations to date
0
Altmetric
Articles

Therapeutic evaluation and prognostic value of interim hybrid PET/CT with 18F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma

, , , &
Pages 423-430 | Published online: 04 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Karen Juul Mylam, Lale Kostakoglu, Martin Hutchings, Morton Coleman, Dominick Lamonica, Myron S. Czuczman, Louis F. Diehl, Anne L. Nielsen, Paw Jensen, Annika Loft, Helle W. Hendel, Victor Iyer, Sirpa Leppä, Sirkku Jyrkkiö, Harald Holte, Mikael Eriksson, Dorte Gillstrøm, Per B. Hansen, Marko Seppänen, Karin Hjorthaug, Peter de Nully Brown & Lars M. Pedersen. (2015) 18F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study. Leukemia & Lymphoma 56:7, pages 2005-2012.
Read now

Articles from other publishers (14)

Andrej Lissat, Claudia van Schewick, Ingo G. Steffen, Ayumu Arakawa, Jean-Pierre Bourquin, Birgit Burkhardt, Guenter Henze, Georg Mann, Christina Peters, Lucie Sramkova, Cornelia Eckert, Arend von Stackelberg & Christiane Chen-Santel. (2021) Other (Non-CNS/Testicular) Extramedullary Localizations of Childhood Relapsed Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma—A Report from the ALL-REZ Study Group. Journal of Clinical Medicine 10:22, pages 5292.
Crossref
Katja N. De Paepe, Ciska-Anne Van KeerberghenGiorgio M. Agazzi, Frederik De KeyzerOlivier GheysensOliver BechterPascal WolterDaan DierickxAnn JanssensGregor VerhoefRaymond OyenMichel Koole & Vincent Vandecaveye. (2021) Quantitative Whole-Body Diffusion-weighted MRI after One Treatment Cycle for Aggressive Non-Hodgkin Lymphoma Is an Independent Prognostic Factor of Outcome. Radiology: Imaging Cancer 3:2, pages e200061.
Crossref
Coreline N. Burggraaff, Antoinette de Jong, Otto S. Hoekstra, Nikie J. Hoetjes, Rutger A. J. Nievelstein, Elise P. Jansma, Martijn W. Heymans, Henrica C. W. de Vet & Josée M. Zijlstra. (2018) Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging 46:1, pages 65-79.
Crossref
SHANBIAO HU, YINHUAI WANG, LUOYAN YANG, LU YI & YEQI NIAN. (2015) Primary non-Hodgkin’s lymphoma of the prostate with intractable hematuria: A case report and review of the literature. Oncology Letters 9:3, pages 1187-1190.
Crossref
Deok-Hwan YangSung-Hoon JungJae-Sook AhnYeo-Kyeoung KimJung-Joon MinHee-Seung BomJe-Jung LeeHyeoung-Joon Kim. (2015) Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma. Chonnam Medical Journal 51:3, pages 109.
Crossref
Karen Juul Mylam, Anne Lerberg Nielsen, Lars Møller Pedersen & Martin Hutchings. (2014) Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma. PET Clinics 9:4, pages 443-455.
Crossref
Ernest K.J. Pauwels, Annette W. Coumou, Magdalena Kostkiewicz & Kalevi Kairemo. (2013) [<sup>18</sup>F]Fluoro-2-Deoxy-<smlcap>D</smlcap>-Glucose Positron Emission Tomography/Computed Tomography Imaging in Oncology: Initial Staging and Evaluation of Cancer Therapy. Medical Principles and Practice 22:5, pages 427-437.
Crossref
Wisut Lamlertthon, Michele C. Hayward & David Neil Hayes. (2011) Emerging Technologies for Improved Stratification of Cancer Patients. The Cancer Journal 17:6, pages 451-464.
Crossref
Amanda F. Cashen, Farrokh Dehdashti, Jingqin Luo, Andrew Homb, Barry A. Siegel & Nancy L. Bartlett. (2011) 18 F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation . Journal of Nuclear Medicine 52:3, pages 386-392.
Crossref
Sébastien Cimarelli, Florence Lachenal, Fabien Ricard, Catherine Chassagne-Clément, Pierre Etienne Heudel, Pierre Janody & Catherine Sebban. (2010) A Case of Advanced Non-Hodgkin's Lymphoma Involving the Prostate. Clinical Nuclear Medicine 35:6, pages 425-427.
Crossref
Birgit BurkhardtAlfred ReiterEva LandmannPeter LangLisa LassayRoswitha DickerhoffMax LakomekGünter HenzeArend von Stackelberg. (2009) Poor Outcome for Children and Adolescents With Progressive Disease or Relapse of Lymphoblastic Lymphoma: A Report From the Berlin-Frankfurt-Muenster Group. Journal of Clinical Oncology 27:20, pages 3363-3369.
Crossref
Deok-Hwan Yang, Jung-Joon Min, Yong Yeon Jeong, Jae-Sook Ahn, Yeo-Kyeoung Kim, Sang-Hee Cho, Ik-Joo Chung, Hee-Seung Bom, Hyeoung-Joon Kim & Je-Jung Lee. (2008) The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin’s lymphoma. Annals of Hematology 88:5, pages 425-432.
Crossref
Yvette L. Kasamon, Richard L. Wahl, Harvey A. Ziessman, Amanda L. Blackford, Steven N. Goodman, Caroline A. Fidyk, Kathryn M. Rogers, Javier Bolaños-Meade, Michael J. Borowitz, Richard F. Ambinder, Richard J. Jones & Lode J. Swinnen. (2009) Phase II Study of Risk-Adapted Therapy of Newly Diagnosed, Aggressive Non-Hodgkin Lymphoma Based on Midtreatment FDG-PET Scanning. Biology of Blood and Marrow Transplantation 15:2, pages 242-248.
Crossref
Ananth Shankar, Frank Fiumara & Ross Pinkerton. (2008) Role of FDG PET in the management of childhood lymphomas – case proven or is the jury still out?. European Journal of Cancer 44:5, pages 663-673.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.